GWPH News and Press, GW Pharmaceuticals Plc From 04/20/21

InvestorPlace - Stock Market News, Stock Advice & Trading Tips It hasn’t been easy to be bullish on marijuana stocks in the last few years. After hitting the market with their own bubble in 2018, pot stocks have had a rough go of it. But that looks to be changing. And it could b...

The European Commission has approved GW Pharmaceuticals' (GWPH) Type II variation application for EPIDYOLEX (cannabidiol) as an adjunctive treatment of seizures associated with tuberous sclerosis complex((TSC)), for patients two years of age and older.TSC, a rare genetic condition, ...

– Tuberous sclerosis complex (TSC) represents a third indication for GW’s cannabidiol in Europe – – TSC causes epilepsy in up to 85% of patients, and up to 60% of those patients do not respond to standard anti-epileptic medicines 1 ,2 ...

Shares of GW Pharmaceuticals Plc (NASDAQ:GWPH) traded at a new 52-week high today of $218.97. Approximately 596,000 shares have changed hands today, as compared to an average 30-day volume of 769,000 shares. In the past 52 weeks, shares of GW Pharmaceuticals Plc have traded between a low...

Real Brands Inc (OTCMKTS:RLBD) is an emerging player on the rejuvenating CBD stock landscape, and one that may deserve attention as a squeeze candidate because the stock has been a target for bears, but one that may be entirely misplaced given the company’s recent strong strides toward...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Economic reports due out next week include the latest updates on existing home sales, new home sales, jobless claims and...

Shares of GW Pharmaceuticals Plc (NASDAQ:GWPH) traded today at $219.00, eclipsing its 52-week high. Approximately 596,000 shares have changed hands today, as compared to an average 30-day volume of 769,000 shares. GW Pharmaceuticals PLC is a biopharmaceutical company focused on discoveri...

Palm Beach, FL – April 15, 2021 – 2020 was a prosperous year for medical marijuana. In fact, North America medical marijuana market size alone was over USD 8.1 billion in 2020. The medical cannabis market has made some remarkable continued growth in revenues. Medical marijuana...

Real Brands Inc (OTCMKTS:RLBD) could be perfectly positioned to rise as one of the emerging winners in CBD Boom 2.0. But first, let’s discuss what that means. Remember CBD? Think back to 2017-18. You simply couldn’t avoid those three letters. If you googled “hot stocks&#x...

EPIDOLEX encore presentations highlight long-term safety and efficacy data in patients with tuberous sclerosis complex (TSC) and other treatment-resistant epilepsies Nabiximols data show efficacy and safety results in patients with spasticity associated with multiple sclerosis ...